应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XRTX XORTX Therapeutics Inc.
盘前交易 07-15 08:29:28 EDT
0.8700
-0.0875
-9.14%
盘前
0.8700
+0.0000
0.00%
08:05 EDT
最高
0.9250
最低
0.8599
成交量
5.22万
今开
0.9100
昨收
0.9575
日振幅
6.80%
总市值
329.58万
流通市值
317.83万
总股本
378.82万
成交额
4.63万
换手率
1.43%
流通股本
365.33万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Xortx Therapeutics Inc.股价重挫15.70% 市值跌50.13万美元
市场透视 · 07-03
Xortx Therapeutics Inc.股价重挫15.70% 市值跌50.13万美元
Xortx Therapeutics Inc.2025财年第一财季实现净利润-698673.00美元,同比增加76.87%
市场透视 · 05-24
Xortx Therapeutics Inc.2025财年第一财季实现净利润-698673.00美元,同比增加76.87%
Xortx Therapeutics Inc.盘中异动 快速下挫10.94%报0.953美元
市场透视 · 05-19
Xortx Therapeutics Inc.盘中异动 快速下挫10.94%报0.953美元
XORTX Therapeutics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.19美元,前值为-1.24美元。
金融界 · 05-19
XORTX Therapeutics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.19美元,前值为-1.24美元。
Xortx Therapeutics Inc.盘中异动 快速上涨5.12%
市场透视 · 05-16
Xortx Therapeutics Inc.盘中异动 快速上涨5.12%
Xortx Therapeutics Inc.盘中异动 股价大跌5.96%报0.930美元
市场透视 · 05-15
Xortx Therapeutics Inc.盘中异动 股价大跌5.96%报0.930美元
Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.48%报1.15美元
市场透视 · 04-28
Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.48%报1.15美元
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.29%报0.895美元
市场透视 · 04-14
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.29%报0.895美元
Xortx Therapeutics Inc.盘中异动 快速上涨5.94%
市场透视 · 03-06
Xortx Therapeutics Inc.盘中异动 快速上涨5.94%
Xortx Therapeutics Inc.盘中异动 急速下挫6.92%
市场透视 · 03-03
Xortx Therapeutics Inc.盘中异动 急速下挫6.92%
Xortx Therapeutics Inc.股价重挫10.38% 市值跌41.5万美元
市场透视 · 02-28
Xortx Therapeutics Inc.股价重挫10.38% 市值跌41.5万美元
Xortx Therapeutics Inc.盘中异动 下午盘股价大涨8.04%报0.900美元
市场透视 · 02-27
Xortx Therapeutics Inc.盘中异动 下午盘股价大涨8.04%报0.900美元
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.55%报0.900美元
市场透视 · 02-26
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.55%报0.900美元
Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.40%
市场透视 · 02-25
Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.40%
Xortx Therapeutics Inc.盘中异动 早盘急速上涨5.50%报0.865美元
市场透视 · 02-24
Xortx Therapeutics Inc.盘中异动 早盘急速上涨5.50%报0.865美元
Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.88%报0.871美元
市场透视 · 02-21
Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.88%报0.871美元
Xortx Therapeutics Inc.盘中异动 股价大跌5.20%报0.910美元
市场透视 · 02-14
Xortx Therapeutics Inc.盘中异动 股价大跌5.20%报0.910美元
Xortx Therapeutics Inc.盘中异动 快速上涨6.74%报0.950美元
市场透视 · 02-06
Xortx Therapeutics Inc.盘中异动 快速上涨6.74%报0.950美元
Xortx Therapeutics Inc.盘中异动 股价大涨6.04%
市场透视 · 02-04
Xortx Therapeutics Inc.盘中异动 股价大涨6.04%
Xortx Therapeutics Inc.盘中异动 急速下挫5.26%报0.900美元
市场透视 · 02-03
Xortx Therapeutics Inc.盘中异动 急速下挫5.26%报0.900美元
加载更多
公司概况
公司名称:
XORTX Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立,名称为ReVasCor Inc.在2018年1月10日,公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司,专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法,这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。
发行价格:
--
{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":0.87,"timestamp":1752523200000,"preClose":0.9575,"halted":0,"volume":52180,"hourTrading":{"tag":"盘前","latestPrice":0.87,"preClose":0.87,"latestTime":"08:05 EDT","volume":42,"amount":36.54,"timestamp":1752581144811},"delay":0,"floatShares":3653254,"shares":3788246,"eps":-0.314477,"marketStatus":"盘前交易","change":-0.0875,"latestTime":"07-15 08:29:28 EDT","open":0.91,"high":0.925,"low":0.8599,"amount":46283.122546,"amplitude":0.06799,"askPrice":0.91,"askSize":300,"bidPrice":0.87,"bidSize":458,"shortable":0,"etf":0,"ttmEps":-0.314477,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752586200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.87,"preHourTrading":{"tag":"盘前","latestPrice":0.87,"preClose":0.87,"latestTime":"08:05 EDT","volume":42,"amount":36.54,"timestamp":1752581144811},"postHourTrading":{"tag":"盘后","latestPrice":0.87,"preClose":0.87,"latestTime":"19:45 EDT","volume":25,"amount":22.6305,"timestamp":1752536748934},"volumeRatio":0.6220020988251592},"requestUrl":"/m/hq/s/XRTX","defaultTab":"news","newsList":[{"id":"2548807465","title":"Xortx Therapeutics Inc.股价重挫15.70% 市值跌50.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548807465?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:31","pubTimestamp":1751549488,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分,Xortx Therapeutics Inc.股票出现异动,股价急速下挫15.70%。截至发稿,该股报0.843美元/股,成交量316.985万股,换手率83.68%,振幅0.20%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Lixte Biotechnology Holdings, Inc.较为活跃,换手率分别为1677.81%、514.10%、437.39%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.,振幅分别为27.18%、26.73%、12.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2538194866","title":"Xortx Therapeutics Inc.2025财年第一财季实现净利润-698673.00美元,同比增加76.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538194866","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538194866?lang=zh_cn&edition=full","pubTime":"2025-05-25 00:00","pubTimestamp":1748102417,"startTime":"0","endTime":"0","summary":"5月25日,Xortx Therapeutics Inc.公布财报,公告显示公司2025财年第一财季净利润为-698673.00美元,同比增加76.87%;其中营业收入为0.00美元,每股基本收益为-0.19美元。从资产负债表来看,Xortx Therapeutics Inc.总负债757350.00美元,其中短期债务15662.00美元,资产负债比为0.01,流动比率为0.01。机构评级:截至2025年5月25日,当前有1家机构对Xortx Therapeutics Inc.目标价做出预测,其中目标均价为14.00美元,其中最低目标价为14.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525000025a48af02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525000025a48af02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ"],"gpt_icon":0},{"id":"2536680524","title":"Xortx Therapeutics Inc.盘中异动 快速下挫10.94%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536680524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536680524?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:33","pubTimestamp":1747661597,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时33分,Xortx Therapeutics Inc.股票出现波动,股价快速跳水10.94%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213317975e64ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213317975e64ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2536685074","title":"XORTX Therapeutics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.19美元,前值为-1.24美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536685074","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536685074?lang=zh_cn&edition=full","pubTime":"2025-05-19 19:01","pubTimestamp":1747652518,"startTime":"0","endTime":"0","summary":"XORTX Therapeutics(XRTX.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.19美元,前值为-1.24美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051919061094fb6cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051919061094fb6cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX"],"gpt_icon":0},{"id":"2535599316","title":"Xortx Therapeutics Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535599316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535599316?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:37","pubTimestamp":1747402622,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时37分,Xortx Therapeutics Inc.股票出现波动,股价快速上涨5.12%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213702a480f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213702a480f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","XRTX"],"gpt_icon":0},{"id":"2535876809","title":"Xortx Therapeutics Inc.盘中异动 股价大跌5.96%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535876809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535876809?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:34","pubTimestamp":1747326848,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时34分,Xortx Therapeutics Inc.股票出现异动,股价快速下挫5.96%。截至发稿,该股报0.930美元/股,成交量1.2383万股,换手率0.33%,振幅4.70%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.71%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516003408a6e095de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516003408a6e095de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","XRTX"],"gpt_icon":0},{"id":"2530289522","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.48%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530289522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530289522?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:30","pubTimestamp":1745847010,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时30分,Xortx Therapeutics Inc.股票出现异动,股价急速上涨6.48%。截至发稿,该股报1.15美元/股,成交量13.537万股,换手率3.57%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213010a46a8d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213010a46a8d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2527216704","title":"Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.29%报0.895美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527216704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527216704?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:59","pubTimestamp":1744639142,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时59分,Xortx Therapeutics Inc.股票出现异动,股价急速上涨5.29%。截至发稿,该股报0.895美元/股,成交量932股,换手率0.02%,振幅6.35%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414215902a6ba2282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414215902a6ba2282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2517654691","title":"Xortx Therapeutics Inc.盘中异动 快速上涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517654691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517654691?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271508,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分,Xortx Therapeutics Inc.股票出现波动,股价快速上涨5.94%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.63%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223148a2628fad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223148a2628fad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","XRTX","BK4139"],"gpt_icon":0},{"id":"2516637978","title":"Xortx Therapeutics Inc.盘中异动 急速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637978?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:58","pubTimestamp":1741013936,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时58分,Xortx Therapeutics Inc.股票出现波动,股价急速跳水6.92%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032258569637b3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032258569637b3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2514378109","title":"Xortx Therapeutics Inc.股价重挫10.38% 市值跌41.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378109?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753030,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分,Xortx Therapeutics Inc.股票出现异动,股价快速下跌10.38%。截至发稿,该股报0.950美元/股,成交量1.2555万股,换手率0.39%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Virpax Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.、Ensysce Biosciences, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为480.20%、239.09%、53.23%,振幅较大的相关个股有Tiziana Life Sciences Ltd、Aardvark Therapeutics, Inc.、Lexeo Therapeutics, Inc.,振幅分别为8.85%、6.22%、4.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030963418f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223030963418f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2514133567","title":"Xortx Therapeutics Inc.盘中异动 下午盘股价大涨8.04%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514133567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514133567?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:04","pubTimestamp":1740679441,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时04分,Xortx Therapeutics Inc.股票出现异动,股价急速上涨8.04%。截至发稿,该股报0.900美元/股,成交量3.5557万股,换手率1.10%,振幅9.60%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228020401abdf9f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228020401abdf9f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2514041856","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.55%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041856?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分,Xortx Therapeutics Inc.股票出现异动,股价急速上涨5.55%。截至发稿,该股报0.900美元/股,成交量122股,换手率0.00%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234549893ab68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234549893ab68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2514090229","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090229?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分,Xortx Therapeutics Inc.股票出现波动,股价大幅拉升6.40%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为746.68%、510.41%、459.93%,振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Pluri Inc.,振幅分别为8.13%、7.46%、7.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223124a2538678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223124a2538678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2513727156","title":"Xortx Therapeutics Inc.盘中异动 早盘急速上涨5.50%报0.865美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727156?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407927,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分,Xortx Therapeutics Inc.股票出现异动,股价大幅上涨5.50%。截至发稿,该股报0.865美元/股,成交量7479股,换手率0.23%,振幅2.09%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223848962e9a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223848962e9a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2513294492","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.88%报0.871美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294492?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:48","pubTimestamp":1740152913,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时48分,Xortx Therapeutics Inc.股票出现异动,股价快速下跌7.88%。截至发稿,该股报0.871美元/股,成交量2.2839万股,换手率0.71%,振幅5.29%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234834abd7c0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234834abd7c0e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","XRTX"],"gpt_icon":0},{"id":"2511561353","title":"Xortx Therapeutics Inc.盘中异动 股价大跌5.20%报0.910美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511561353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511561353?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:31","pubTimestamp":1739554275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时31分,Xortx Therapeutics Inc.股票出现异动,股价快速下跌5.20%。截至发稿,该股报0.910美元/股,成交量1.2959万股,换手率0.40%,振幅5.19%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.62%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013116a24627cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013116a24627cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XRTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2509272797","title":"Xortx Therapeutics Inc.盘中异动 快速上涨6.74%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272797?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:50","pubTimestamp":1738853402,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时50分,Xortx Therapeutics Inc.股票出现波动,股价急速拉升6.74%。截至发稿,该股报0.950美元/股,成交量1570股,换手率0.05%,振幅6.74%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225003abc4d95f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225003abc4d95f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2508457719","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457719?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:36","pubTimestamp":1738679804,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时36分,Xortx Therapeutics Inc.股票出现波动,股价大幅上涨6.04%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223644a23929f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223644a23929f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2508403231","title":"Xortx Therapeutics Inc.盘中异动 急速下挫5.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508403231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508403231?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:51","pubTimestamp":1738597861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时51分,Xortx Therapeutics Inc.股票出现波动,股价急速下跌5.26%。截至发稿,该股报0.900美元/股,成交量1.538万股,换手率0.48%,振幅5.26%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.67%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235101abc11890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235101abc11890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","XRTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":-0.0169},{"period":"3month","weight":-0.0333},{"period":"6month","weight":-0.2091},{"period":"1year","weight":-0.5538},{"period":"ytd","weight":-0.2298}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立,名称为ReVasCor Inc.在2018年1月10日,公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司,专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法,这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.161819},{"month":2,"riseRate":0.5,"avgChangeRate":0.055515},{"month":3,"riseRate":0.5,"avgChangeRate":0.09248},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051078},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010505},{"month":6,"riseRate":0.25,"avgChangeRate":-0.056347},{"month":7,"riseRate":0.25,"avgChangeRate":-0.028256},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059348},{"month":9,"riseRate":0,"avgChangeRate":-0.142465},{"month":10,"riseRate":0,"avgChangeRate":-0.308198},{"month":11,"riseRate":0.25,"avgChangeRate":-0.090311},{"month":12,"riseRate":0,"avgChangeRate":-0.088816}],"exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}